Product Description: Cirtuvivint (SM08502) is a potent and orally active CDC-like kinase (CLK) inhibitor. Cirtuvivint can be used for solid tumors research[1].
Applications: Cancer-Kinase/protease
Formula: C24H25N7O
References: [1]Betty Y Tam, et al. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models. Cancer Lett. 2020 Mar 31;473:186-197.
CAS Number: 2143917-62-6
Molecular Weight: 427.50
Compound Purity: 98.28
Research Area: Cancer
Solubility: DMSO : 12.5 mg/mL (ultrasonic;warming;heat to 60°C)/H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)